Find link
language:
af: Afrikaans
als: Alemannisch
[Alemannic]
am: አማርኛ
[Amharic]
an: aragonés
[Aragonese]
ar: العربية
[Arabic]
arz: مصرى
[Egyptian Arabic]
as: অসমীয়া
[Assamese]
ast: asturianu
[Asturian]
az: azərbaycanca
[Azerbaijani]
azb: تۆرکجه
[Southern Azerbaijani]
ba: башҡортса
[Bashkir]
bar: Boarisch
[Bavarian]
bat-smg: žemaitėška
[Samogitian]
be: беларуская
[Belarusian]
be-tarask: беларуская (тарашкевіца)
[Belarusian (Taraškievica)]
bg: български
[Bulgarian]
bn: বাংলা
[Bengali]
bpy: বিষ্ণুপ্রিয়া মণিপুরী
[Bishnupriya Manipuri]
br: brezhoneg
[Breton]
bs: bosanski
[Bosnian]
bug: ᨅᨔ ᨕᨘᨁᨗ
[Buginese]
ca: català
[Catalan]
ce: нохчийн
[Chechen]
ceb: Cebuano
ckb: کوردیی ناوەندی
[Kurdish (Sorani)]
cs: čeština
[Czech]
cv: Чӑвашла
[Chuvash]
cy: Cymraeg
[Welsh]
da: dansk
[Danish]
de: Deutsch
[German]
el: Ελληνικά
[Greek]
en: English
eo: Esperanto
es: español
[Spanish]
et: eesti
[Estonian]
eu: euskara
[Basque]
fa: فارسی
[Persian]
fi: suomi
[Finnish]
fo: føroyskt
[Faroese]
fr: français
[French]
fy: Frysk
[West Frisian]
ga: Gaeilge
[Irish]
gd: Gàidhlig
[Scottish Gaelic]
gl: galego
[Galician]
gu: ગુજરાતી
[Gujarati]
he: עברית
[Hebrew]
hi: हिन्दी
[Hindi]
hr: hrvatski
[Croatian]
hsb: hornjoserbsce
[Upper Sorbian]
ht: Kreyòl ayisyen
[Haitian]
hu: magyar
[Hungarian]
hy: Հայերեն
[Armenian]
ia: interlingua
[Interlingua]
id: Bahasa Indonesia
[Indonesian]
io: Ido
is: íslenska
[Icelandic]
it: italiano
[Italian]
ja: 日本語
[Japanese]
jv: Basa Jawa
[Javanese]
ka: ქართული
[Georgian]
kk: қазақша
[Kazakh]
kn: ಕನ್ನಡ
[Kannada]
ko: 한국어
[Korean]
ku: Kurdî
[Kurdish (Kurmanji)]
ky: Кыргызча
[Kirghiz]
la: Latina
[Latin]
lb: Lëtzebuergesch
[Luxembourgish]
li: Limburgs
[Limburgish]
lmo: lumbaart
[Lombard]
lt: lietuvių
[Lithuanian]
lv: latviešu
[Latvian]
map-bms: Basa Banyumasan
[Banyumasan]
mg: Malagasy
min: Baso Minangkabau
[Minangkabau]
mk: македонски
[Macedonian]
ml: മലയാളം
[Malayalam]
mn: монгол
[Mongolian]
mr: मराठी
[Marathi]
mrj: кырык мары
[Hill Mari]
ms: Bahasa Melayu
[Malay]
my: မြန်မာဘာသာ
[Burmese]
mzn: مازِرونی
[Mazandarani]
nah: Nāhuatl
[Nahuatl]
nap: Napulitano
[Neapolitan]
nds: Plattdüütsch
[Low Saxon]
ne: नेपाली
[Nepali]
new: नेपाल भाषा
[Newar]
nl: Nederlands
[Dutch]
nn: norsk nynorsk
[Norwegian (Nynorsk)]
no: norsk bokmål
[Norwegian (Bokmål)]
oc: occitan
[Occitan]
or: ଓଡ଼ିଆ
[Oriya]
os: Ирон
[Ossetian]
pa: ਪੰਜਾਬੀ
[Eastern Punjabi]
pl: polski
[Polish]
pms: Piemontèis
[Piedmontese]
pnb: پنجابی
[Western Punjabi]
pt: português
[Portuguese]
qu: Runa Simi
[Quechua]
ro: română
[Romanian]
ru: русский
[Russian]
sa: संस्कृतम्
[Sanskrit]
sah: саха тыла
[Sakha]
scn: sicilianu
[Sicilian]
sco: Scots
sh: srpskohrvatski / српскохрватски
[Serbo-Croatian]
si: සිංහල
[Sinhalese]
simple: Simple English
sk: slovenčina
[Slovak]
sl: slovenščina
[Slovenian]
sq: shqip
[Albanian]
sr: српски / srpski
[Serbian]
su: Basa Sunda
[Sundanese]
sv: svenska
[Swedish]
sw: Kiswahili
[Swahili]
ta: தமிழ்
[Tamil]
te: తెలుగు
[Telugu]
tg: тоҷикӣ
[Tajik]
th: ไทย
[Thai]
tl: Tagalog
tr: Türkçe
[Turkish]
tt: татарча/tatarça
[Tatar]
uk: українська
[Ukrainian]
ur: اردو
[Urdu]
uz: oʻzbekcha/ўзбекча
[Uzbek]
vec: vèneto
[Venetian]
vi: Tiếng Việt
[Vietnamese]
vo: Volapük
wa: walon
[Walloon]
war: Winaray
[Waray]
yi: ייִדיש
[Yiddish]
yo: Yorùbá
[Yoruba]
zh: 中文
[Chinese]
zh-min-nan: Bân-lâm-gú
[Min Nan]
zh-yue: 粵語
[Cantonese]
jump to random article
Find link is a tool written by Edward Betts .
searching for SGLT2 inhibitor 3 found (33 total)
alternate case: sGLT2 inhibitor
Sodium-glucose transport proteins
(1,628 words)
[view diff]
case mismatch in snippet
view article
find links to article
Sodhi K, Shapiro JI (December 2021). "The Na/K-ATPase Signaling and SGLT2 Inhibitor -Mediated Cardiorenal Protection: A Crossed Road?". review. The Journal
Spiroketals
(528 words)
[view diff]
no match in snippet
view article
find links to article
Ring System, as a Highly Selective Sodium Glucose Cotransporter 2 (SGLT2 ) Inhibitor for the Treatment of Type 2 Diabetes". Journal of Medicinal Chemistry
Vlado Perkovic
(1,368 words)
[view diff]
exact match in snippet
view article
find links to article
Committee, the first trial to convincingly demonstrate the benefits of the SGLT2 inhibitor canagliflozin on the risk of kidney failure and cardiovascular outcomes